147 related articles for article (PubMed ID: 10099998)
1. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and therapy of low-risk endometrial hyperplasia. Experience with LH-RH-A].
Pace S; Stentella P; Frega A; Palazzetti PL; Nobili F; Figliolini M; Grassi A
Minerva Ginecol; 1992 Dec; 44(12):645-51. PubMed ID: 1491773
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hyperplasia endometrium with GNRH agonists].
Radowicki S; Skórzewska K
Ginekol Pol; 2003 Sep; 74(9):836-9. PubMed ID: 14674133
[TBL] [Abstract][Full Text] [Related]
4. [Use of a GnRH analogue in the treatment of certain forms of endometrial hyperplasia associated with menometrorrhagia].
Bonfirraro G; Sanna B; De Marco A; Chieffi O; Bonfirraro PP; Orlando V
Minerva Ginecol; 1995 Oct; 47(10):467-70. PubMed ID: 8559438
[TBL] [Abstract][Full Text] [Related]
5. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
6. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
Pérez-Medina T; Bajo J; Folgueira G; Haya J; Ortega P
Gynecol Oncol; 1999 May; 73(2):299-304. PubMed ID: 10329050
[TBL] [Abstract][Full Text] [Related]
7. Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
Mesci-Haftaci S; Ankarali H; Yavuzcan A; Caglar M
Asian Pac J Cancer Prev; 2014; 15(8):3737-40. PubMed ID: 24870785
[TBL] [Abstract][Full Text] [Related]
8. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
Haoula ZJ; Walker KF; Powell MC
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
11. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
Kim MK; Seong SJ; Kim JW; Jeon S; Choi HS; Lee IH; Lee JH; Ju W; Song ES; Park H; Ryu HS; Lee C; Kang SB
Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333
[TBL] [Abstract][Full Text] [Related]
12. Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia.
Agorastos T; Vaitsi V; Paschopoulos M; Vakiani A; Zournatzi-Koiou V; Saravelos H; Kostopoulou E; Constantinidis T; Dinas K; Vavilis D; Lolis D; Bontis J
Maturitas; 2004 Jun; 48(2):125-32. PubMed ID: 15172086
[TBL] [Abstract][Full Text] [Related]
13. The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation.
Neuspiller F; Levy M; Remohí J; Ruiz A; Simón C; Pellicer A
Hum Reprod; 1998 May; 13(5):1148-51. PubMed ID: 9647536
[TBL] [Abstract][Full Text] [Related]
14. Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses.
Marra C; Penati C; Ferrari L; Cantù MG; Bargossi L; Fruscio R
Gynecol Endocrinol; 2014; 30(12):899-901. PubMed ID: 25111756
[TBL] [Abstract][Full Text] [Related]
15. [Endometrial hyperplasia: A review].
Brun JL; Descat E; Boubli B; Dallay D
J Gynecol Obstet Biol Reprod (Paris); 2006 Oct; 35(6):542-50. PubMed ID: 17003742
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
Zhou H; Cao D; Yang J; Shen K; Lang J
Int J Gynecol Cancer; 2017 Jul; 27(6):1178-1182. PubMed ID: 28562472
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of simple endometrial hyperplasia with GnRH analogs. Evaluation of a multicentric ambulatory study. Preliminary results].
Zagni R; Cortelazzi R; Cipolla L; Giannetta G; Ferrante B; Soliani A
Minerva Ginecol; 1993 Dec; 45(12):597-602. PubMed ID: 8139785
[TBL] [Abstract][Full Text] [Related]
19. Digital morphometry of cytologic aspirate endometrial samples.
Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
[TBL] [Abstract][Full Text] [Related]
20. Low-risk endometrial hyperplasia: hysteroscopy and histologic evaluation after treatment with LH-RH analogue.
Pace S; Figliolini M; Grassi A; Franceschini P; Pachì A
Clin Exp Obstet Gynecol; 1994; 21(2):79-86. PubMed ID: 8070121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
